InvestorsHub Logo
Followers 10
Posts 1765
Boards Moderated 0
Alias Born 09/19/2019

Re: Piper jr1 post# 43891

Thursday, 06/11/2020 2:35:18 PM

Thursday, June 11, 2020 2:35:18 PM

Post# of 54913
• Proven management team with success from R&D, to operations and commercialization.
Still nothing commercialized.

• First product line - internally developed Human Cell and Tissue Products - launched in 2017
Yep nothing much in sales threw away more product in the last 2 qrts. than they sold.

• Launched 2 novel, genetic-based endometriosis and fertility diagnostic/prognostic tests in Dec. 2018
UMM where's the sales then if they launched them? Art-guide is still doing retrograde studies.

• Broad, follow-on pipeline of diagnostics and therapeutics in the near-, mid-, and longterm.

Yes Atrin deal. Still have hope they might make some money on that in a few years.


• Cash positive operating position with no debt (only operating payables)

$250k on hand as of last month, $1.7 mill gov't loan to stay afloat. MULTI-Millions in debt. $551k lawsuit for non-payment of services.


• Pursuing a near-term NASDAQ listing

NOPE delisted 2x persuiting to stay in business and to get back to stink pinkies. As of now stuck in gray land for how long????

How much has changed for the worse in past 12 months.